Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001654954-25-003382
Filing Date
2025-03-27
Accepted
2025-03-27 09:56:49
Documents
1
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4/A  
1 PRIMARY DOCUMENT section16.xml 4/A 12120
  Complete submission text file 0001654954-25-003382.txt   13691
Mailing Address C/O ZOMEDICA CORP. 100 PHOENIX DRIVE, SUITE 125 ANN ARBOR MI 48018
Business Address
Rowe Jeffrey M (Reporting) CIK: 0001619009 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38298 | Film No.: 25775908

Mailing Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Corp. (Issuer) CIK: 0001684144 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)